	2024	2025	2026	2027	2028
Revenue	21,783	22,848	23,967	24,932	26,193
Dividend	0.87	1.00	1.17	-	-
Dividend Yield (in %)	2.57 %	2.94 %	3.43 %	3.43 %	3.27 %
EPS	2.89	3.41	3.85	4.39	4.70
P/E Ratio	11.75	9.97	8.82	7.73	7.23
EBIT	2,319	2,689	2,945	3,194	3,427
EBITDA	3,528	3,962	4,217	4,485	-
Net Profit	1,171	1,872	2,121	2,442	2,588
Net Profit Adjusted	1,591	1,909	2,175	2,472	2,648
Pre-Tax Profit	1,814	2,337	2,648	2,855	3,136
Pre-Tax Profit Reported	1,395	2,275	2,633	2,899	3,207
EPS (Non-GAAP) ex. SOE	-	-	-	-	-
EPS (GAAP)	1.69	3.28	3.73	4.40	4.59
Gross Income	5,142	5,770	6,149	6,643	6,980
Cash Flow from Investing	-720	-1,294	-1,354	-1,333	-1,393
Cash Flow from Operations	2,625	2,778	3,035	3,307	3,543
Cash Flow from Financing	-952	-667	-686	-870	-925
Cash Flow per Share	4.23	4.75	5.13	-	-
Free Cash Flow	1,455	1,642	1,861	-	-
Free Cash Flow per Share	2.59	2.64	3.01	-	-
Book Value per Share	35.46	37.66	40.42	-	-
Net Debt	12,402	11,708	10,766	-	-
Research & Development Exp.	658	683	715	676	708
Capital Expenditure	1,202	1,248	1,305	1,254	1,313
Selling, General & Admin. Exp.	2,978	2,803	2,910	2,846	2,939
Shareholder’s Equity	19,938	21,052	22,604	23,500	25,155
Total Assets	45,170	46,402	47,799	49,249	50,959

	Previous Quarter ending 09/30/24	Current Quarter ending 12/31/24	Next Quarter ending 03/31/25	Current Year ending 12/31/24	Next Year ending 12/31/25
Earnings Estimates
No. of Analysts	5	5	-	14	14
Average Estimate	0.678 EUR	0.786 EUR	-	2.892 EUR	3.406 EUR
Year Ago	-0.728 EUR	-1.090 EUR	-	-1.055 EUR	-
Publish Date	11/6/2024	2/19/2025	-	-	-
Revenue Estimates
No. of Analysts	4	4	-	12	12
Average Estimate	5,385 EUR	5,673 EUR	-	21,783 EUR	22,848 EUR
Year Ago	5,518 EUR	5,678 EUR	-	22,299 EUR	-
Publish Date	11/6/2024	2/19/2025	-	-	-

* Average Estimates in Million (e.g. Revenue) or per share (e.g. Dividend). Source: FactSet

Income Statements in Mio. EUR

	2023	2022	2021	2020	2019	2018	2017
Sales	22,299.00	40,637.00	37,077.00	36,277.00	35,409.00	33,530.00	33,886.00
Change of sales in %	-45.13	9.60	2.21	2.45	5.60	-1.05	14.98
Gross profit on sales	5,058.00	10,522.00	9,809.00	10,316.00	10,348.00	9,818.00	10,461.00
Gross profit on sales change in %	-51.93	7.27	-4.91	-0.31	5.40	-6.15	10.15
Operating income	1,296.00	2,969.00	3,600.00	4,144.00	4,321.00	4,215.00	4,379.00
Operating income change in %	-56.35	-17.53	-13.13	-4.10	2.51	-3.75	2.58
Income before tax	727.00	2,746.00	3,559.00	3,726.00	3,912.00	4,664.00	3,938.00
Income before tax change in %	-73.53	-22.84	-4.48	-4.75	-16.12	18.44	5.86
Income after tax	-594.00	1,372.00	1,818.00	1,707.00	1,883.00	2,027.00	1,814.00
Income after tax change in %	-	-24.53	6.50	-9.35	-7.10	11.74	16.28

Balance Sheet in Mio. EUR

	2023	2022	2021	2020	2019	2018	2017
Total liabilities	25,633.00	44,197.00	42,674.00	40,623.00	40,426.00	31,695.00	31,413.00
Long-term liabilities per share	28.95	54.77	49.95	49.66	48.39	33.14	37.45
Equity	19,651.00	32,218.00	29,288.00	26,023.00	26,580.00	25,008.00	21,720.00
Equity change in %	-6.94	7.46	12.09	1.02	8.87	12.81	7.87
Balance sheet total	45,284.00	76,415.00	71,962.00	66,646.00	67,006.00	56,703.00	53,133.00
Balance sheet total change in %	-40.74	6.19	7.98	-0.54	18.17	6.72	13.78

Key Data in EUR

	2023	2022	2021	2020	2019	2018	2017
Sales per share	39.59	72.40	66.43	65.04	63.52	60.16	60.78
P/E ratio (year end quote, basic EPS)	-	10.74	10.87	12.36	14.84	11.62	19.90
P/E ratio (year end quote, diluted EPS)	-	10.74	10.87	12.36	14.85	11.66	20.02
P/E ratio (year end quote)	-	10.74	10.87	12.36	14.84	11.62	19.90
Dividend yield in %	0.00	3.50	2.60	2.33	1.67	1.89	1.15
Equity ratio in %	43.40	42.16	40.70	39.05	39.67	44.10	40.88
Debt ratio in %	56.60	57.84	59.30	60.95	60.33	55.90	59.12

Fresenius Dividend Calendar

Date	Name	Dividend	*yield	Currency
2023	Fresenius SE & Co. KGaA (St.)	0.00	0.00	EUR
2022	Fresenius SE & Co. KGaA (St.)	0.92	3.50	EUR
2021	Fresenius SE & Co. KGaA (St.)	0.92	2.60	EUR
2020	Fresenius SE & Co. KGaA (St.)	0.88	2.33	EUR
2019	Fresenius SE & Co. KGaA (St.)	0.84	1.67	EUR
2018	Fresenius SE & Co. KGaA (St.)	0.80	1.89	EUR
2017	Fresenius SE & Co. KGaA (St.)	0.75	1.15	EUR
2016	Fresenius SE & Co. KGaA (St.)	0.62	0.83	EUR
2015	Fresenius SE & Co. KGaA (St.)	0.55	0.83	EUR
2014	Fresenius SE & Co. KGaA (St.)	0.44	1.02	EUR
2013	Fresenius SE & Co. KGaA (St.)	0.42	1.12	EUR
2012	Fresenius SE & Co. KGaA (St.)	0.37	1.26	EUR
2011	Fresenius SE & Co. KGaA (St.)	0.32	1.33	EUR
2010	Fresenius SE & Co. KGaA (St.)	0.29	1.37	EUR
2009	Fresenius SE & Co. KGaA (St.)	0.25	1.73	EUR
2008	Fresenius SE & Co. KGaA (St.)	0.23	1.93	EUR
2007	Fresenius SE & Co. KGaA (St.)	0.22	1.18	EUR
2006	Fresenius SE & Co. KGaA (St.)	0.19	1.13	EUR
2005	Fresenius SE & Co. KGaA (St.)	0.16	1.38	EUR
2004	Fresenius SE & Co. KGaA (St.)	0.15	1.81	EUR
2003	Fresenius SE & Co. KGaA (St.)	0.14	1.91	EUR
2002	Fresenius SE & Co. KGaA (St.)	0.13	3.17	EUR
2001	Fresenius SE & Co. KGaA (St.)	0.11	1.26	EUR
2000	Fresenius SE & Co. KGaA (St.)	0.10	0.85	EUR

*Yield of the Respective Date

Fresenius Calendar

Event	Estimate	Info	Date
Earnings Report	0.678 EUR	Q3 2024 Earnings Release	11/06/2024
Earnings Report	0.787 EUR	Q4 2024 Earnings Release	02/19/2025
Earnings Report	-	Q1 2025 Earnings Release	05/01/2025
Earnings Report	-	Q2 2025 Earnings Release	08/05/2025
Earnings Report	-	Q3 2025 Earnings Release	11/04/2025

Fresenius Past Events

Event	Actual EPS	Info	Date
Earnings Report	-0.662 EUR	Q2 2024 Earnings Release	07/31/2024

Fresenius Profile

Fresenius SE & Co. KGaA is a healthcare group, which engages in the provision of products and services for dialysis, hospitals, and outpatient medical care. It operates through the following segments: Fresenius Medical Care, Fresenius Kabi, Fresenius Helios and Fresenius Vamed. The Fresenius Medical Care segment caters to individuals with renal diseases. The Fresenius Kabi segment specializes in lifesaving medicines and technologies. The Fresenius Helios offers expertise in inpatient and outpatient care as well as in telemedicine. The Fresenius Vamed segment manages projects and services for hospitals and other healthcare facilities. The company was founded by Eduard Fresenius on October 1, 1912 and is headquartered in Bad Homburg, Germany.

Moody’s Daily Credit Risk Score

Risk

Low
Medium
High

Moody’s Daily Credit Risk Score is a 1-10 score of a company’s credit risk, based on an analysis of the firm’s balance sheet and inputs from the stock market. The score provides a forward-looking, one-year measure of credit risk, allowing investors to make better decisions and streamline their work ow. Updated daily, it takes into account day-to-day movements in market value compared to a company’s liability structure.

Fresenius Shareholder

Owner	in %
Freefloat	72.99
Else Kröner-Fresenius-Stiftung	27.00
Harris Associates LP	2.99
Oakmark International Fund	2.53
Amundi Asset Management SA (Investment Management)	2.44
Government Pension Fund - Global (The)	1.52
Vanguard Total International Stock Index Fund	1.02
BNP Paribas Easy S&P 500 UCITS ETF	0.88
Franklin Mutual Ser. Fds. - Global Discovery Fund	0.85

Shareholder percentage totals can add to more than 100% because some holders are included in the free float.

Fresenius Management

Name	Job
Wolfgang Kirsch	Chairman-Supervisory Board
Michael Sen	Chief Executive Officer
Pierluigi Antonelli	Chief Executive Officer-Fresenius Kabi
Sara Hennicken	Chief Financial Officer
Michael Moser	Head-Legal & Compliance
Susanne Zeidler	Independent Member-Supervisory Board
Michael Albrecht	Independent Member-Supervisory Board
Bernd Behlert	Independent Member-Supervisory Board
Iris Löw-Friedrich	Independent Member-Supervisory Board
Holger Michel	Member-Supervisory Board
Oscar Romero de Paco	Member-Supervisory Board
Konrad Kölbl	Member-Supervisory Board
Christoph Zindel	Member-Supervisory Board
Frauke Lehmann	Member-Supervisory Board
Alexandra Graulich	Secretary & Head-Corporate Communications
Markus Georgi	Senior VP-Investor Relations & Sustainability
Michael Diekmann	Vice Chairman-Supervisory Board
Grit Genster	Vice Chairman-Supervisory Board